Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
3,050.00
+65.00 (2.18%)
At close: Nov 13, 2026
| Market Cap | 183.50B -25.5% |
| Revenue (ttm) | 50.34B -39.5% |
| Net Income | -32.83B |
| EPS | -620.86 |
| Shares Out | 60.16M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 59,236 |
| Open | 3,000.00 |
| Previous Close | 2,985.00 |
| Day's Range | 2,955.00 - 3,070.00 |
| 52-Week Range | 2,070.00 - 6,430.00 |
| Beta | -0.53 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 17, 2026 |